LLY: Eli Lilly and Company Amount of Cash per Share

Eli Lilly and Company - graphic logo of issuer LLY

The cash per share chart for Eli Lilly and Company (LLY) on GURU.Markets shows an upward trend, where the value 5.14 describes the current liquidity level. The automation of drug synthesis via neural networks is driving this growth. Exclusive patents in diabetes therapy form the foundation of profits, while the high cost of innovative drugs amid colossal demand guarantees the company a stable cash generator.

LLY - Eli Lilly & Co. Cash per Share over the range 07/04/2022 - 11/20/2026

Analytical breakdowns for Eli Lilly and Company

- market value and analyst target forecast:
- market capitalization information:
- cash availability and cash flow indicators:
General company analysis:LLY (Eli Lilly and Company)
Brand item of lilly.com

This ratio reflects the relationship between net liquidity and the number of common shares, allowing for an assessment of the internal financial reserve per share. By analyzing the calculated cash per share, an investor can see how expenditures on synthesis robotization and neural network molecule discovery at Eli Lilly and Company (LLY) impact the company's margin of safety, determining the stability of its investment profile.